Loading organizations...
Key people at CVS Health Ventures.
CVS Health Ventures is a corporate venture capital fund based in Woonsocket, Rhode Island, that invests in early-stage digital healthcare technology companies. Operating as the captive venture arm of its parent corporation, the firm launched with an initial $100 million fund allocation to back startups focused on healthcare accessibility, affordability, and overall operational efficiency. The investment vehicle leverages a broad national ecosystem comprising nearly 10,000 retail pharmacy locations and approximately 100 million individual customers across the Caremark and Aetna networks to help scale its strategic investments. The firm's active portfolio includes prominent digital health and enterprise software companies such as Unite Us and HealthEdge, which benefit from direct integration into the broader corporate infrastructure and distribution channels. Managed by a dedicated two-person investment team, CVS Health Ventures was established in 2021 by its parent company, CVS Health.
Key people at CVS Health Ventures.
CVS Health Ventures is a corporate venture capital fund launched by CVS Health in 2021 with an initial $100 million allocation to invest in early-stage companies driving innovation in accessible, affordable, and simpler health care.[1][2] Its mission aligns with CVS Health's purpose of "Bringing our heart to every moment of your health" by partnering with high-potential startups that enhance connectivity between patients and providers, address interconnected health determinants (physical, behavioral, psychological, social), simplify patient-focused care, and fill ecosystem gaps with new technologies.[1][2] The fund targets value-based, technology-oriented solutions across digital health, with over 20 portfolio companies to date, more than 60% of which have established business relationships with CVS Health, amplifying its impact on the startup ecosystem through capital, expertise, and scaling opportunities via CVS's national footprint and omnichannel presence.[1]
CVS Health Ventures was established in 2021 as a dedicated arm of CVS Health, a diversified health services company with over 300,000 employees and a focus on transforming care delivery.[1][2][3] The fund emerged from CVS Health's track record in scaling innovation, led by executives like Karen S. Lynch (President and CEO), who emphasized consumer-centered, digitally enabled solutions, and Josh Flum (Executive Vice President, Enterprise Strategy & Business Development), who highlighted leveraging CVS's experience to provide capital and commercial partnerships for rapid scaling.[2] Its evolution centers on CVS Health's core strategy of redefining health care through community presence, tech-forward approaches, and engagement with over 100 million people, shifting from traditional models to integrated, empathetic systems.[1][3]
CVS Health Ventures rides the trend toward digitally enabled, patient-centric health care amid rising demands for accessible, affordable solutions outside traditional settings like hospitals.[1][2] Its timing capitalizes on CVS Health's evolution into a leading health solutions company with strong community ties and tech integration, countering market forces like health disparities, chronic disease burdens, and fragmented care delivery.[3] By investing in connectivity, holistic well-being, simplified access, and innovative gap-fillers, the fund influences the ecosystem by accelerating startup adoption through CVS's scale—fostering a more empathetic, value-based model that reshapes national care delivery.[1]
CVS Health Ventures is poised to expand its portfolio and deepen integrations as digital health matures, with trends like AI-driven personalization, social determinants-focused interventions, and omnichannel care gaining momentum.[1][3] Its influence may evolve by pioneering corporate-startup synergies, potentially growing beyond $100 million to lead in empathetic, tech-anchored health innovation. This positions it centrally in building "healthier futures," echoing its launch promise of heart-centered, accessible care for all.[1][2]
CVS Health Ventures has 14 tracked investments across 11 companies. The latest tracked deal is $35.0M Series C in Codoxo in February 2026.